Sign in
8-K

Current Report

Protalix BioTherapeutics, Inc. Filed Acc 0001144204-19-014447

Results of operations · Restatement

  • Item 2.02 Results of operations and financial condition
  • Item 4.02 Non-reliance on previously issued financial statements

From the SEC's structured data for this filing

Loading tv516469_8k.htm…